1. Bayliss EA, Reifler LM, Zeng C et al (2014) Competing risks of cancer mortality and cardiovascular events in individuals with multimorbidity. J Comorbidity 4(1):29–36
2. Clayton JM, Hancock KM, Butow PN et al (2007) Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust 186(12):S77–S108
3. Currow DC, Clark K, Kamal A et al (2015) The population burden of chronic symptoms that substantially predate the diagnosis of a life-limiting illness. J Palliat Med 18(6):480–485
4. Rushton M, Clark R, Brideson G, Damarell R (2015) The effectiveness of non-pharmacological interventions for the management of cancer treatment-induced cardiotoxicity: a systematic review protocol. JBI Database Syst Rev Implementation Rep 13(5):53–73
5. Hunt SA, Abraham WT, Chin MH et al (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). American College of Cardiology. Available at: http://www.acc.org/clinical/guidelines/failure//index.pdf